The CORE Library small molecule screening compound stock is a total of more than 600,000 leadlike and druglike small molecule compounds based on novel scaffolds and designs created by ChemBridge. This stock includes 3D, sp3-enriched compounds and grows by approx. 80,000 compounds per year. Customer and custom select from the CORE Library stock.
Structurally diverse pre-plated diversity set with high-scoring chemical features created using compounds from ChemBridge's CORE Library screening compound stock and ChemBridge's EXPRESS-Pick Collection screening compound stock.
Nuclear receptor-directed selection from ChemBridge's CORE Library screening compound stock.
Pre-selected SAR set composed of compounds from ChemBridge's CORE Library screening compound stock.
Ion channel-directed selection from ChemBridge's CORE Library screening compound stock.
ChemBridge has developed a diverse, easily modifiable collection of macrocycles intended to be accessible to both industry and academic researchers. The Macrocycle Library compounds are based on a collection of novel synthetic macrocyclic scaffolds with some based on natural products. ChemBridge chemists developed synthetic strategies for the synthesis and functionalization of macrocyclic compounds and to date have developed o…
The EXPRESS-Pick small molecule screening compound stock is a collection of 460,000 druglike, small molecule compounds, available for custom selection.
Structurally diverse small molecule libraries with broad 3D pharmacophore coverage for hit identification ChemBridge offers two, complementary DIVERSet™ Libraries, each composed of 50,000 leadlike and druglike compounds. Both DIVERSet Libraries (the DIVERSet-EXP and the DIVERSet-CL) are designed to provide the greatest coverage of pharmacophore space within 50,000 compounds while maintaining chemical structure diversity. Th…
CNS-directed selection from ChemBridge's EXPRESS-Pick Collection screening compound stock.
Pre-plated selection from ChemBridge's EXPRESS-Pick Collection screening compound stock.
Ion channel-directed selection from ChemBridge's EXPRESS-Pick Collection screening compound stock.
GPCR-targeted compounds based on beta-turn mimetic scaffolds designed by ChemBridge.
Kinase-directed selection from ChemBridge's EXPRESS-Pick Collection screening compound stock.
Kinase-directed selection from ChemBridge's CORE Library screening compound stock.
Our non-exclusive building block collection, consisting of over 12,000 products, has been developed to support advanced combinatorial lead generation, hit-to-lead, lead optimization and medicinal chemistry programs. The vast majority of our building blocks are not available from any other commercial source listed in ACD.
ChemBridge Fragment Library compounds for fragment-based drug discovery and screening.
